Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continuous radiosensitizing chemotherapy].

C Hennequin1, C Maylin

  • 1Hôpital Saint-Louis, Paris, France.

Pathologie-Biologie
|April 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

[Antimicrobial peptides: A new alternative for the treatment of aspergillosis].

Revue des maladies respiratoires·2024
Same author

Withdrawal notice to "Changes in the fungal nomenclature: why and how to manage?" [J Mycol Med 33 (2023) 101387].

Journal de mycologie medicale·2023
Same author

[Targeted systemic treatments and locoregional radiotherapy for breast cancer: Can we expect a benefit from the potentiation of local treatment?]

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

Continuous infusion of 5-fluorouracil (5FU) combined with radiation therapy improves survival for rectal cancer patients. This approach enhances disease-free and overall survival compared to traditional bolus 5FU therapy.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Chemistry

Context:

  • Concomitant radiation therapy and chemotherapy are increasingly utilized for locally-advanced epithelial tumors.
  • This combined modality has demonstrated efficacy in various cancers, including head and neck, esophageal, and lung cancers.
  • 5-fluorouracil (5FU) is a well-established radiation sensitizer, with in vitro studies highlighting the benefit of continuous exposure post-irradiation.

Purpose:

  • To evaluate the efficacy of continuous infusion 5-fluorouracil (5FU) compared to bolus 5FU in conjunction with radiation therapy for rectal cancer.
  • To assess the impact of different 5FU administration methods on disease-free survival and overall survival in rectal cancer patients undergoing chemoradiotherapy.

Summary:

  • A randomized study in rectal cancer demonstrated superior outcomes with continuous infusion 5FU during irradiation versus bolus 5FU therapy.

Related Experiment Videos

  • Patients receiving continuous 5FU infusion exhibited longer disease-free survival and overall survival.
  • Other radiation sensitizers like cisplatin and etoposide are also gaining traction, often requiring central venous access for administration and nutritional support.

    • Impact:

    • Continuous infusion 5FU represents a more effective strategy for chemoradiotherapy in rectal cancer, improving patient survival.
    • The findings support the biological rationale for sustained drug exposure during and after radiation to maximize radiosensitization.
    • This highlights the importance of optimizing drug delivery schedules in combined modality cancer treatment.